Cardiac accidents of locoregional anaesthesia: Experimental study of risk factors with bupivacaine;Accidents cardiaques de l'anesthésie locorégionale: Étude expérimentale des facteurs de risque avec la bupivacaïne

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 2, 1998, Pages 217-232

  Timour, Quadiri ^a   Gaillard, Perrine ^a   Bui Xuan, Bernard ^a   Vial, Thierry ^a   Evreux, Jean Claude ^a   Freysz, Marc ^b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Anesthesia, Conduction, adverse effects; Anesthetics, Local; Bupivacaine; Hyperkalemia; Hyponatremia; Hypothermia; Myocardial Ischemia

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT;

ACCIDENT; ANIMAL; ARTICLE; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DOG; RISK FACTOR; SWINE;

ACCIDENTS; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CARDIOMYOPATHIES; DOGS; RISK FACTORS; SWINE;

EID: 0031608916     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. HOTVEDT R., REFSUM H., HELGESEN K.G. - Cardiac efectrocardiographic and hemodynamic effects related to plasma levels of bupivacaine in the dog. Anesth. Analg., 1985, 64, 388-394.
2. TIMOUR Q., FREYSZ M., LANG J., BEAL J.L., LAKHAL M., BERTRIX L., FAUCON G. - Electrophysiological study in the dog of the risk of cardiac toxicity of bupivacaine. Arch. Int. Pharmacodyn.,1987, 287, 63-77.
3. DE JONG R., GAMBLE C.A., BONIN J.D. - Bupivacaine causes arrhythmias in normokalemic cats, lidocaine does not. Reg. Anesth.,1982, 7, 84-85.
4. KOTELKO D.M., SHNIDER S.M., DAILEY P.A. Bupivacaine-induced cardiac arrhyhmias in sheep. Anesthesiology,1985, 62, 382-384.
5. TANZ R.D., HESKETT T., LOEHNIG R.W., FAIRFAX C.A. - Comparative cardiotoxicity of bupivacaine and lidocaine in the isolated perfused mammalian heart. Anesth. Analg.,1984, 63, 549-556.
6. BEAL J.L., FREYSZ M., TIMOUR Q., BERTRIX L., LANG J., FAUCON G. - Haemodynamic effects of high plasma concentrations of bupivacaine in the dog. fur. J. Anaesth., 1988, 5, 251-260.
7. WHEELER D.M., BRADLEY E.L., WOODS W.T.Jr. The electrophysiologic actions of lidocaine and bupivacaine in the isolated, perfused canine heart. Anesthesiohgy, 1988, 65, 201-212.
8. AUPETIT J.F., TIMOUR Q., LOUFOUA-MOUNDANGA J., BARRAL-CADIERE L., LOPEZ M., FREYSZ M., FAUCON G. - Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. J.Cardiovasc. Pharmacol., 1995, 25, 810-816.
9. TUCKER G.T., MATHER L.E. - Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. Br. J. Anaesth.,1975, 47, 213-224.
10. LAKHAL M., TIMOUR Q., BERTRIX L., LANG J., BEAL J.L., FREYSZ M., FAUCON G. - Taux plasmatiques de bupivacaïne faisant suite àdes anesthésies locorégionales de divers types et toxicité cardiaque. Thérapie, 1988, 43, 25-31.
11. TUOMINEN M., ROSENBERG P.H., KALSO E. - Blood levels of bupivacaine after single dose, supplementary dose and during continuous infusion in axillary plexus block. Acta Anaesthesiol. Scand.,1983, 27, 303-306.
12. TAKASAKI M. - Blood concentrations of lidocaine, mepivacaine and bupivacaine during caudal analgesia in children. Acta Anaesthesiol. Scand.,1984, 28, 211-214.
13. TIMOUR Q., FREYSZ M., COUZON P., LOUFOUA J., BERTRIX L., GERENTES I., FAUCON G. Possible role of drug interactions in bupivacaine-induced problems related to intraventricular conduction disorders. Reg. Anesth.,1990, 15, 180-185.
14. JANSE M.J., WIT A.L. - Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev.,1989, 69, 1049-1169.
15. LYONS C.J., BURGESS M.J., ABILDSKOV J.A. - Effect of acute hyperkalemia on cardiac excitability. Am. Heart J.,1977, 94, 755-763.
16. WIT A.L., WEISS M.B., BERKOWITZ W.D., ROSEN K.M., STEINER C., DAMATO A.N. - Pattern of atrioventricular conduction in the human heart. Circ. Res.,1970, 27, 345-359.
17. AUPETIT J.F., TIMOUR Q., CHEVREL G., LOUFOUA-MOUNDANGA J., OMAR S., FAUCON G. Attenuation of the ischaemia-induced fall of electrical threshold for fibrillation by a calcium antagonist, diltiazem. Naunyn-Schmiedeberg's Arch.Pharmacol.,1993, 348, 509-514.
18. AUPETIT J.F., FREYSZ M., FAUCON G., LOUFOUA J., TIMOUR Q. - Change of a beneficial effect into an untoward effect by ischaemia : effect of quinidine-like drugs on vulnerability to ventricular fibrillation. Environm. Toxicol. Pharmacol., 1996, 2, 1-7.
19. AUPETIT J.F., LOUFOUA-MOUNDANGA J., FAUCON G., TIMOUR Q. - Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. Br. J. Pharmacol.,1997, 120, 523-529.
20. REUTER H. - Ion channels in cardiac cell membranes. Annu. Rev. Physiol.,1984, 46, 473-484.
21. TIMOUR Q., FREYSZ M., MAZZE R.I., COUZON P., BERTRIX L., FAUCON G. Enhancement by hyponatremia and hyperkalemia of ventricular conduction and rhythm disorders caused by bupivacaine. Anesthesiology, 1990, 72,1051-1056.
22. BUI-XUAN B., AUPETIT J.F., FREYSZ M., LOUFOUA J., FAUCON G, TIMOUR Q. - Cardiac β-adrenoceptor activation and ventricular fibrillation under normal and ischaemic conditions. Cardiovasc. Res.,1996, 32, 1056-1063.
23. AUPETIT J.F., FRASSATI D., BUI-XUAN B., FREYSZ M., FAUCON G., TIMOUR Q. - Efficacy of a β-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Cardiovasc. Res., in press.
24. LANG J., TIMOUR Q., CHARVE P., AUPETIT J.F., EL. CHEBLY M., FAUCON G. - Role of calcium in the rate-dependent depression of atrioventricular nodal conduction in the dog heart under vagal influence. Int. J. Cardiol.,1987, 15, 65-76.
25. WEIDMANN S. - The effect of the cardiac membrane potential on the rapid availability of the sodium carrying system. J. Physiol. (Lond.),1955, 127, 213-224.
26. PRAKASH O., JOHNSON B., Bos E., MEU S., HUGENHOLTZ P.O., HERMAN W. - Cardiorespiratory and metabolic effects of profound hypothermia. Crit. Care Med.,1978, 6, 340-346.
27. FREYSZ M., TIMOUR Q., MAZZE R.I., BERTRIX L., COHEN S., SAMII K., FAUCON G. - Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in the dog. Anesthesiology,1989, 70, 799-804.
28. FREYSZ M., TIMOUR Q., BERTRIX L., LOUFOUA-MOUNDANGA J., OMAR S., FAUCON G. Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine. Acta Anaesthesiol. Scand.,1993, 37, 350-356.
29. FREYSZ M., TMOUR Q., BERTRIX L., LOUFOUA J., AUPETIT J.F., FAUCON G. - Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold. Anesth. Analg.,1995, 80, 657-663.
30. BUI-XUAN B., AUPETIT J.F., FREYSZ M., LOUFOUA-MOUNDANGA J., FAUCON G., TIMOUR Q. Disappearance with ischaemic depolarisation of the antifibrillatory activity in a sodium channel blocker and appearance in a calcium channel blocker. Arch. Int. Pharmacodyn.,1996, 331, 246-262.